Reward 500 Tiger-coinsA new congressional disclosure has once again reignited debate around tracking lawmakers’ trades.
Nancy Pelosi reported roughly $69 million in recent transactions, highlighted by the sale of about $50 million worth of $Apple(AAPL)$, along with reductions in $NVIDIA(NVDA)$ and $Walt Disney(DIS)$
At the same time, Pelosi added new LEAP call options on $Alphabet(GOOGL)$ , $Amazon.com(AMZN)$, $Apple(AAPL)$, and $NVIDIA(NVDA)$ , using far less capital to retain upside exposure.
The message is subtle but important: this is less about turning bearish on tech and more about locking in gains while maintaining long-term optionality.
In contrast, Congressman Kevin Hern disclosed a complete exit from his roughly $500,000 position in $UnitedHealth(UNH)$, marked as “sell to close.”
Notably, Hern sits on the House health subcommittee. Shortly after, healthcare stocks sold off sharply, with UNH plunging nearly 20% as investors reacted to weaker guidance and looming Medicare reimbursement pressure.
Together, these trades illustrate two very different approaches. Pelosi’s strategy emphasizes capital efficiency and risk management, while Hern’s move signals a full de-risking ahead of policy-driven uncertainty.
For individual investors, the key question remains whether these trades are actionable signals—or simply reflections of access and tools most retail traders don’t have.
-
How do you interpret Pelosi’s recent trade?
-
Is there any takeaway for retail investors?
-
Should retail investors “follow” congressional trades?
-
After UNH’s sharp sell-off, where is a good dip-buy level?
Leave your comments to win tiger coins~
For SG users only, Welcome to open a CBA today and enjoy access to a trading limit of up to SGD 20,000 with unlimited trading on SG, HK, and US stocks, as well as ETFs.
Find out more here.
Complete your first Cash Boost Account trade with a trade amount of ≥ SGD1000* to get SGD 688 stock vouchers*! The trade can be executed using any payment type available under the Cash Boost Account: Cash, CPF, SRS, or CDP.
Other helpful links:
Comments
Members of Congress also often have access to financial tools & potentially non public information or unique insights not available to the average investor.
More importantly their trades might be influenced by their personal circumstances which are not relevant to an individual investor's goals.
@Tiger_SG @Tiger_comments @TigerStars @TigerClub @CaptainTiger
For retail investors, the lesson isn’t to copy congressional trades, but to understand the thinking behind them. Most retail traders can’t size or structure trades the same way, so blindly following disclosures rarely works. What does help is learning when to take profits and how to maintain exposure without overcommitting capital.
$UnitedHealth(UNH)$ is a different story. After the sharp sell-off, I wouldn’t rush to buy the dip. I’d wait for the stock to stabilize around longer-term support and for policy risks to be better priced in. In healthcare names, patience usually beats trying to be early.
@Tiger_SG @TigerStars @Tiger_comments @TigerClub
This clears or minimises abuse of information.
Then again with a Headso muddled, it's a cowboy country really.
So it helps to track and mimick their patterns.
Even the classic movie Sabrina and it's subsequent remake says so too.
Due to delayed disclosures, congressional trades often lack full context, including hedges, options, or portfolio shifts; a sale could signal profit-taking or reallocation rather than a bearish stance
Recent UNH sale preceded a sharp sell-off, driven by weak guidance, regulatory pressure, and Medicare Advantage issues, pushing stock down。。。
UNH trades at lower valuations than usual, with some analysts seeing it as discounted due to long-term cash flow, though ongoing policy challenges and regulatory risks warrant caution
For retail investors, congressional trades inspire research, but the real edge lies in disciplined strategy; blindly copying trades raises timing risk, especially with volatile stocks like UNH